Showing results (11-20 of 31) with videos related to

Sort By:
Pageof 4
Diagnostics (Basel, Switzerland)|December 24, 2021
Comparison of Two Blood-Based Genotyping Tests to Investigate the KRAS G12C Mutation in Patients with Non-Small-Cell Lung Cancer at Failure of First-Line TreatmentsChiara Nicolazzo, Alain Gelibter, Irene Bottillo, et al.
Clinical Biochemistry|April 15, 2015
Validation of the Ion Torrent PGM sequencing for the prospective routine molecular diagnostic of colorectal cancerFrancesca Belardinilli, Carlo Capalbo, Amelia Buffone, et al.
Cancers|July 27, 2019
Circulating Tumor Cells in Right- and Left-Sided Colorectal CancerChiara Nicolazzo, Cristina Raimondi, Angela Gradilone, et al.
Peerj|May 9, 2019
Next-generation sequencing of BRCA1 and BRCA2 genes for rapid detection of germline mutations in hereditary breast/ovarian cancerArianna Nicolussi, Francesca Belardinilli, Yasaman Mahdavian, et al.
Frontiers in Immunology|December 4, 2023
Impact of SARS-CoV-2 vaccination on FcγRIIIA/CD16 dynamics in Natural Killer cells: relevance for antibody-dependent functionsCristina Capuano, Davide De Federicis, Daniel Ciuti, et al.
Frontiers in Oncology|April 17, 2023
Genomic landscape and survival analysis of ctDNA "neo-RAS wild-type" patients with originally RAS mutant metastatic colorectal cancerChiara Nicolazzo, Valentina Magri, Luca Marino, et al.
Cancer Biology & Therapy|April 24, 2014
Vemurafenib and panitumumab combination tailored therapy in BRAF-mutated metastatic colorectal cancer: a case reportCarlo Capalbo, Paolo Marchetti, Anna Coppa, et al.
Pathology, Research and Practice|March 1, 2021
A multidisciplinary approach for the differential diagnosis between multiple primary lung adenocarcinomas and intrapulmonary metastasesFrancesca Belardinilli, Angelina Pernazza, Yasaman Mahdavian, et al.
Cancer Medicine|December 23, 2017
Optimizing the identification of risk-relevant mutations by multigene panel testing in selected hereditary breast/ovarian cancer familiesAnna Coppa, Arianna Nicolussi, Sonia D'Inzeo, et al.
Cancer Letters|March 21, 2021
True conversions from RAS mutant to RAS wild-type in circulating tumor DNA from metastatic colorectal cancer patients as assessed by methylation and mutational signatureChiara Nicolazzo, Ludovic Barault, Salvatore Caponnetto, et al.
Pageof 4